Research progress in the diagnosis, treatment, and prognosis of metastatic uveal melanoma

Authors: Yu Jinhai, Wang Yaohua, Liao Hongfei
DOI: 10.3760/cma.j.cn115989-20230808-00062
   

Citation

Yu Jinhai, Wang Yaohua, Liao Hongfei. Research progress in the diagnosis, treatment, and prognosis of metastatic uveal melanoma[J]. Chin J Exp Ophthalmol, 2025, 43(9):846-851.

DOI: 10.3760/cma.j.cn115989-20230808-00062.

ABSTRACT                  [Download PDF] [View Full Text]

Metastatic uveal melanoma (MUM) is a rare but highly invasive ocular malignant tumor with poor prognosis.At present, there is a lack of standardized methods for the treatment of MUM, resulting in poor prognosis.However, in recent years, the emergence of immune checkpoint inhibitors, new immune drug Tebenfos, comprehensive targeted therapy, combined sequential therapy and other treatment methods has brought new hope to MUM patients.This review aims to summarize the latest progress in the diagnosis, treatment, and prognosis of MUM.

Metastatic uveal melanoma;Immune checkpoint inhibitors;Clinical trials

Authors Info & Affiliations

Yu Jinhai
The Affiliated Eye Hospital of Nanchang University, Nanchang 330006, China
Wang Yaohua
The Affiliated Ophthalmic Hospital of Wenzhou Medical University, Wenzhou 325027, China
Liao Hongfei
The Affiliated Eye Hospital of Nanchang University, Nanchang 330006, China
(Read 9 times, 1 visits today)